NCT04230980View on ClinicalTrials.gov

Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

July 28, 2020

Primary Completion Date

November 28, 2022

Study Completion Date

December 16, 2022

Conditions
Non-obstructive Azoospermia
Interventions
DRUG

Gabapentin

Gabapentin 600mg tablet

DRUG

Placebo

Placebo tablet

Trial Locations (1)

10065

Weill Cornell Medicine, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT04230980 - Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery | Biotech Hunter | Biotech Hunter